BCB Medical is the Nordic market leader in gathering and analysing clinical data. Our mission is to combine, analyze and illustrate clinical data gathered from various sources and present it in an understandable format so that current and future generations can live healthier lives. Our aim is to revolutionize the way clinical data impacts people’s lives. We help doctors provide better care for their patients and help them develop new forms of treatment to improve patients’ lives.

Our unique service offering encompasses disease-specific quality registries for healthcare professionals, an intelligent integration platform and the MyHealth-service, which engages patients in their own clinical care. The overall offering is complemented by the BCB Data & Analytics, which enables the utilisation of clinical data in an unprecedented way.

Edwards Lifesciences Corporation is the global leader in patient-focused medical innovations for structural heart disease and critical care monitoring. Driven by a passion to help patients, we partner with the world’s leading clinicians and researchers and invest in research and development to transform care for those impacted by structural heart disease or who require hemodynamic monitoring during surgery or in intensive care.  Edwards Lifesciences has a proud six-decade history as a leader in these areas. Since our founder, Lowell Edwards, first dreamed of using engineering to address diseases of the human heart, we have steadily built a company on the premise of imagining, building, and realizing a better future for patients.

A pioneer in the development of heart valve therapies, we are the world’s leading manufacturer of heart valve systems and repair products used to replace or repair a patient’s diseased or defective heart valve. Our innovative work in heart valves encompasses both surgical and transcatheter therapies for heart valve replacement and repair.  We are also a global leader in hemodynamic monitoring systems used to measure a patient’s cardiovascular function in the hospital setting.

My Clinical Outcomes (MCO) is a configurable web platform that helps healthcare providers to improve value for patients and payers by systematically using patient-reported outcomes measurement to improve patient access, enhance clinical decision-making and reduce unnecessary activity and cost, in routine clinical practice.

MCO was first recognised as an affiliate of ICHOM in 2014, the same year Founder and CEO, Dr Tim Williams attended Prof. Porter’s Value Based Healthcare seminar at Harvard Business School.

MCO have assembled a team of specialist developers, analysts and implementation specialists to work directly with healthcare providers, including in the UK with multiple NHS Trusts and Spire Healthcare, a private provider with 39 sites, as well with charities such as Macmillan Cancer Support, and industry partners such as Novartis.

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 80,000 employees with sales and services in more than 100 countries.